Document is current
Any future updates will be listed below
-
Authors
Dipaola, Maria Greta
Perugini, Eleonora
Mancini, Giulia
Gennari, Nicolò
Serini, Paola
Bevivino, Giulia
Borean, Alessio
Lombardo, Fabrizio
Pombi, Marco
Montarsi, Fabrizio
Gabrieli, Paolo
Forneris, Federico
Arcà, Bruno
-
Funding
Funding for this research was provided by:
Sapienza Università di Roma (PhD program in Infectious Diseases, Microbiology and Public Health, RM124190FDE3A264)
EU funding within the NextGeneration EU-MUR PNRR Extended Partnership initiative on Emerging Infectious Diseases (PE00000007 INF-ACT)
- License Information
-
More Information
Article History
Received: 11 July 2025
Accepted: 19 October 2025
First Online: 19 November 2025
Declarations
:
: This study was conceived according to good clinical practices and followed the ethical principles recommended by the Edinburgh revision of the Helsinki declaration. The protocol was approved by the Ethics Committee of Sapienza University (306/17 RIF.CE: 4479 10 April 2017). All volunteers participating in the study provided written informed consent on the use of their sera to measure antibody responses to mosquito salivary antigens.
: Not applicable.
: The authors declare no competing interests.
